US 12171768
IRAK4 degraders and uses thereof
granted A61KA61K31/5386A61K9/0053
Quick answer
US patent 12171768 (IRAK4 degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/5386, A61K9/0053, A61K9/1635, A61K9/1652